Younossi ZM - Search Results

1

Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection.

Younossi ZM, Park H, Saab S, Ahmed A, Dieterich D, Gordon SC. Younossi ZM, et al. Aliment Pharmacol Ther. 2015 Mar;41(6):544-63. doi: 10.1111/apt.13081. Epub 2015 Jan 26. Aliment Pharmacol Ther. 2015. PMID: 25619871 Free article.

2

A pharmacoeconomic appraisal of therapies for hepatitis B and C.

Younossi ZM, Temple ME, Shermock KM. Younossi ZM, et al. Expert Opin Pharmacother. 2001 Feb;2(2):205-11. doi: 10.1517/14656566.2.2.205. Expert Opin Pharmacother. 2001. PMID: 11336580 Review.

3

Interferon alpha 2B and ribavirin in severe recurrent cholestatic hepatitis C.

Ong JP, Younossi ZM, Gramlich T, Goodman Z, Mayes J, Sarbah S, Yen-Lieberman B. Ong JP, et al. Among authors: younossi zm. Transplantation. 2001 May 27;71(10):1486-7. doi: 10.1097/00007890-200105270-00023. Transplantation. 2001. PMID: 11391241

4

Non-alcoholic fatty liver disease and hepatitis C infection.

Bondini S, Younossi ZM. Bondini S, et al. Among authors: younossi zm. Minerva Gastroenterol Dietol. 2006 Jun;52(2):135-43. Minerva Gastroenterol Dietol. 2006. PMID: 16557185 Review.

5

Health-related quality of life in patients with non-alcoholic fatty liver disease.

Dan AA, Kallman JB, Wheeler A, Younoszai Z, Collantes R, Bondini S, Gerber L, Younossi ZM. Dan AA, et al. Among authors: younossi zm. Aliment Pharmacol Ther. 2007 Sep 15;26(6):815-20. doi: 10.1111/j.1365-2036.2007.03426.x. Aliment Pharmacol Ther. 2007. PMID: 17767465 Free article.

6

Adipokines and cytokines in non-alcoholic fatty liver disease.

Jarrar MH, Baranova A, Collantes R, Ranard B, Stepanova M, Bennett C, Fang Y, Elariny H, Goodman Z, Chandhoke V, Younossi ZM. Jarrar MH, et al. Among authors: younossi zm. Aliment Pharmacol Ther. 2008 Mar 1;27(5):412-21. doi: 10.1111/j.1365-2036.2007.03586.x. Epub 2007 Dec 10. Aliment Pharmacol Ther. 2008. PMID: 18081738 Free article.

7

A phase II dose finding study of darbepoetin alpha and filgrastim for the management of anaemia and neutropenia in chronic hepatitis C treatment.

Younossi ZM, Nader FH, Bai C, Sjogren R, Ong JP, Collantes R, Sjogren M, Farmer D, Ramsey L, Terra K, Gujral H, Gurung C, Srishord M, Fang Y. Younossi ZM, et al. J Viral Hepat. 2008 May;15(5):370-8. doi: 10.1111/j.1365-2893.2007.00956.x. Epub 2008 Jan 10. J Viral Hepat. 2008. PMID: 18194172 Clinical Trial.

8

Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.

Younossi ZM. Younossi ZM. Aliment Pharmacol Ther. 2008 Jul;28(1):2-12. doi: 10.1111/j.1365-2036.2008.03710.x. Epub 2008 Apr 11. Aliment Pharmacol Ther. 2008. PMID: 18410557 Free article. Review.

9

Screening for hepatitis B, C and non-alcoholic fatty liver disease: a survey of community-based physicians.

Kallman JB, Arsalla A, Park V, Dhungel S, Bhatia P, Haddad D, Wheeler A, Younossi ZM. Kallman JB, et al. Among authors: younossi zm. Aliment Pharmacol Ther. 2009 May 1;29(9):1019-24. doi: 10.1111/j.1365-2036.2009.03961.x. Aliment Pharmacol Ther. 2009. PMID: 19220207 Free article.

10

Predictors of health-related quality of life in patients with chronic liver disease.

Afendy A, Kallman JB, Stepanova M, Younoszai Z, Aquino RD, Bianchi G, Marchesini G, Younossi ZM. Afendy A, et al. Among authors: younossi zm. Aliment Pharmacol Ther. 2009 Sep 1;30(5):469-76. doi: 10.1111/j.1365-2036.2009.04061.x. Epub 2009 Jun 9. Aliment Pharmacol Ther. 2009. PMID: 19508612 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

580 results

Search Page